Otsuka America Pharmaceutical, Inc

Matched from indexed company URL: OTSUKA AMERICA

FDA Registration(s)#

Registration, FEI, Name table
RegistrationFEINameStatusInitial importerExpiration yearAddress
30107428843010742884Otsuka America Pharmaceutical, Inc1N2026-01-013956 Point Eden Way Hayward CA US 94545
30007184063000718406OTSUKA AMERICA PHARMACEUTICAL, INC.1Y2020-04-252440 Research Blvd Rockville MD US 20850

GUDID Contact Samples#

Sampled from matched GUDID device records for this company; this is not an exhaustive company contact directory.

Source GUDID, Product, Phone table
Source GUDIDProductPhoneEmail
00857335005053MyCite Patch - DW5 replacement patch609.535.9659michael.fahmy@otsuka-us.com
00857335005053MyCite Patch - DW5 replacement patch410-353-8778nancy.teague@otsuka-us.com
00857335005091MyCite Patch - 2 component patch RW2609.535.9659michael.fahmy@otsuka-us.com

Registered Device Listings#

Registration key, Listing key, Premarket submission table
Registration keyListing keyPremarket submissionDeviceProduct codeDecision date
688471993667191P100025BREATHTEK UBT FOR H. PYLORI KIT AND PEDIATRIC UREA HYDROLYSIS RATE CALCULATION APPLICATION (PUHR-CA), VERSION 1.0OZA2012-02-22
2830761490004324K251088Otsuka Digital Feedback DeviceOZW2025-06-30
688472021951238K014225BREATHTEK - UBIT UBT FOR H. PYLORIMSQ2002-01-17

Product Codes Associated With Registrations#

Product code, Registration listing records, Latest decision table
Product codeRegistration listing recordsLatest decision
OZW12025-06-30
OZA12012-02-22
MSQ12002-01-17

NDC#

ABILIFY

Otsuka America Pharmaceutical, Inc.

ARIPIPRAZOLE

ABILIFY

Otsuka America Pharmaceutical, Inc.

ARIPIPRAZOLE

ABILIFY

Otsuka America Pharmaceutical, Inc.

ARIPIPRAZOLE

ABILIFY

Otsuka America Pharmaceutical, Inc.

ARIPIPRAZOLE

ABILIFY

Otsuka America Pharmaceutical, Inc.

ARIPIPRAZOLE

ABILIFY

Otsuka America Pharmaceutical, Inc.

ARIPIPRAZOLE

SAMSCA

Otsuka America Pharmaceutical, Inc.

tolvaptan

SAMSCA

Otsuka America Pharmaceutical, Inc.

tolvaptan

Rexulti

Otsuka America Pharmaceutical, Inc.

brexpiprazole

Rexulti

Otsuka America Pharmaceutical, Inc.

brexpiprazole

Rexulti

Otsuka America Pharmaceutical, Inc.

brexpiprazole

Rexulti

Otsuka America Pharmaceutical, Inc.

brexpiprazole

Rexulti

Otsuka America Pharmaceutical, Inc.

brexpiprazole

Rexulti

Otsuka America Pharmaceutical, Inc.

brexpiprazole

Rexulti

Otsuka America Pharmaceutical, Inc.

BREXPIPRAZOLE

Rexulti

Otsuka America Pharmaceutical, Inc.

BREXPIPRAZOLE

Nuedexta

Otsuka America Pharmaceutical, Inc

dextromethorphan hydrobromide and quinidine sulfate

BUSULFEX

Otsuka America Pharmaceutical, Inc.

busulfan

Jynarque

Otsuka America Pharmaceutical, Inc.

tolvaptan

Jynarque

Otsuka America Pharmaceutical, Inc.

tolvaptan

JYNARQUE

Otsuka America Pharmaceutical, Inc.

tolvaptan

JYNARQUE

Otsuka America Pharmaceutical, Inc.

tolvaptan

Jynarque

Otsuka America Pharmaceutical, Inc.

tolvaptan

Jynarque

Otsuka America Pharmaceutical, Inc.

tolvaptan

Jynarque

Otsuka America Pharmaceutical, Inc.

tolvaptan

VOYXACT

Otsuka America Pharmaceutical, Inc.

sibeprenlimab

PMA#

PMN#

Rejoyn

2024-03-30

Otsuka America Pharmaceutical, Inc.

Applications#

GUDID#

Otsuka Digital Feedback Device - The wearable sensor in the Otsuka Digital Feedback Device is a body-worn sensor that consists of a single-use patch known as the D-Tect wearable sensor or D-Tect Patch. The D-Tect Patch collects physiological and behavioral metrics such as heart rate, activity, body angle, and time stamped patient-logged events, including events signaled by the co-incidence with, or co-ingestion with, the ingestible sensor accessory. Note: While the device includes automated heart rate (HR) measurement, it does not provide an ECG waveform recording for display or analysis. The device is not intended to diagnose heart-related conditions and does not include alarms. HR measurement is not intended to be used in alarm system. HR data may not be accurate for patients with pacemakers.

Otsuka America Pharmaceutical Inc

2026-05-11

BreathTek® UBT for H. pylori Kit (BreathTek UBT Kit) - The BreathTek® UBT for H. pylori Kit (BreathTek UBT Kit) is intended for use in the qualitative detection of urease associated with H. pylori in the human stomach and is indicated as an aid in the initial diagnosis and post-treatment monitoring of H. pylori infection in adults, and pediatric patients 3 to 17 years old. The test may be used for monitoring treatment if used at least 4 weeks following completion of therapy. For these purposes, the system utilizes an Infrared Spectrophotometer for the measurement of the ratio of 13CO2 to 12CO2 in breath samples, in clinical laboratories and point-of-care settings. The Pediatric Urea Hydrolysis Rate Calculation Application (pUHR-CA), provided as a web-based calculation program, is required to obtain pediatric test results.The BreathTek UBT Kit is for administration by a health care professional, as ordered by a licensed health care practitioner.

Otsuka America Pharmaceutical Inc

2017-05-16